Clonality/NN
of/IN
isolated/VBN
eosinophils/NNS
in/IN
the/DT
hypereosinophilic/JJ
syndrome/NN
./.

The/DT
idiopathic/JJ
hypereosinophilic/JJ
syndrome/NN
(/(
IHES/NN
)/)
is/VBZ
a/DT
rare/JJ
disorder/NN
characterized/VBN
by/IN
unexplained/JJ
,/,
persistent/JJ
eosinophilia/NN
associated/VBN
with/IN
multiple/JJ
organ/NN
dysfunction/NN
due/JJ
to/TO
eosinophilic/JJ
tissue/NN
infiltration/NN
./.
=====
In/IN
the/DT
absence/NN
of/IN
karyotypic/JJ
abnormalities/NNS
,/,
there/EX
is/VBZ
no/DT
specific/JJ
test/NN
to/TO
detect/VB
clonal/JJ
eosinophilia/NN
in/IN
IHES/NN
./.
=====
Analysis/NN
of/IN
X-chromosome/NN
inactivation/NN
patterns/NNS
can/MD
be/VB
used/VBN
to/TO
determine/VB
whether/IN
proliferative/JJ
disorders/NNS
are/VBP
clonal/JJ
in/IN
origin/NN
./.
=====
Methylation/NN
of/IN
HpaII/NN
and/CC
Hha/NN
I/CD
sites/NNS
near/IN
the/DT
polymorphic/JJ
trinucleotide/NN
repeat/NN
of/IN
the/DT
human/JJ
androgen/NN
receptor/NN
gene/NN
(/(
HUMARA/NN
)/)
has/VBZ
been/VBN
shown/VBN
to/TO
correlate/VB
with/IN
X-inactivation/NN
./.
=====
In/IN
this/DT
study/NN
,/,
we/PRP
have/VBP
used/VBN
the/DT
polymerase/NN
chain/NN
reaction/NN
(/(
PCR/NN
)/)
with/IN
nested/JJ
primers/NNS
to/TO
analyze/VB
X-inactivation/JJ
patterns/NNS
of/IN
the/DT
HUMARA/NN
loci/NNS
in/IN
purified/VBN
eosinophils/NNS
from/IN
female/JJ
patients/NNS
with/IN
eosinophilia/NN
./.
=====
Peripheral/JJ
blood/NN
eosinophils/NNS
were/VBD
isolated/VBN
by/IN
their/PRP$
autofluoresence/NN
using/VBG
flow/NN
cytometric/JJ
sorting/NN
./.
=====
Eosinophils/NNS
purified/VBN
from/IN
a/DT
female/JJ
patient/NN
presenting/VBG
with/IN
IHES/NN
were/VBD
found/VBN
to/TO
show/VB
a/DT
clonal/JJ
pattern/NN
of/IN
X-inactivation/NN
./.
=====
Eosinophil-depleted/JJ
leukocytes/NNS
from/IN
this/DT
patient/NN
were/VBD
polyclonal/JJ
by/IN
HUMARA/NN
analysis/NN
,/,
thus/RB
excluding/VBG
skewedness/NN
of/IN
random/JJ
X-/JJ
inactivation/NN
./.
=====
After/IN
corticosteroid/NN
suppression/NN
of/IN
her/PRP$
blood/NN
eosinophilia/NN
,/,
a/DT
clonal/JJ
population/NN
of/IN
eosinophils/NNS
could/MD
no/RB
longer/RB
be/VB
detected/VBN
in/IN
purified/JJ
eosinophils/NNS
./.
=====
In/IN
contrast/NN
,/,
eosinophils/NNS
purified/VBN
from/IN
a/DT
patient/NN
with/IN
Churg-Strauss/JJ
syndrome/NN
and/CC
from/IN
six/CD
patients/NNS
with/IN
reactive/JJ
eosinophilias/NNS
attributed/VBN
to/TO
allergy/NN
,/,
parasitic/JJ
infection/NN
,/,
or/CC
drug/NN
reaction/NN
showed/VBD
a/DT
polyclonal/JJ
pattern/NN
of/IN
X-inactivation/NN
by/IN
HUMARA/NN
analysis/NN
./.
=====
The/DT
finding/NN
of/IN
clonal/JJ
eosinophilia/NN
in/IN
a/DT
patient/NN
presenting/VBG
with/IN
IHES/NN
indicates/VBZ
that/IN
such/JJ
patients/NNS
may/MD
have/VB
,/,
in/IN
reality/NN
,/,
a/DT
low-grade/JJ
clonal/JJ
disorder/NN
that/WDT
can/MD
be/VB
distinguished/VBN
from/IN
reactive/JJ
eosinophilias/NNS
by/IN
HUMARA/NN
analysis/NN
./.
=====
Further/RB
,/,
the/DT
method/NN
described/VBN
can/MD
be/VB
used/VBN
to/TO
monitor/VB
disease/NN
progression/NN
./.